Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6250
+0.0750 (4.84%)
NASDAQ · Last Trade: Nov 11th, 2:06 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors